Conservative scenario: Revenue keep increasing at 10%, NPAT remains 12% of Revenue so it also increases 10% a year.
P/E steady at 10, SP should move between 1.5 and 2.
Also if they keep delivering growth the forward P/E may be more aggessive hence a SP of 2-4 bucks could be seen again.
It's all speculation and depends on what the strategy outlook is when they present it in 2 months
- Forums
- ASX - By Stock
- Ann: FY22 Results Presentation
BVS
bravura solutions limited.
Add to My Watchlist
0.90%
!
$2.24

Conservative scenario: Revenue keep increasing at 10%, NPAT...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.24 |
Change
0.020(0.90%) |
Mkt cap ! $1.004B |
Open | High | Low | Value | Volume |
$2.21 | $2.30 | $2.20 | $1.937M | 859.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 16253 | $2.22 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.26 | 6753 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3652 | 2.190 |
3 | 30000 | 2.180 |
2 | 18216 | 2.170 |
1 | 450 | 2.150 |
1 | 7000 | 2.140 |
Price($) | Vol. | No. |
---|---|---|
2.260 | 500 | 1 |
2.300 | 815 | 1 |
2.310 | 236 | 1 |
2.320 | 740 | 1 |
2.400 | 1580 | 2 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
BVS (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online